Pure Global AI
Disease / condition

Alzheimer's Disease clinical trials

Free access to 801 studies10+ countriesUpdated daily58 recruiting
VerifiedClinicalTrials.gov · WHO ICTRP · regional registries
801
Total trials
10+
Countries
10+
Sponsors
58
Recruiting
By phase
N/A242
Phase 2187
Phase 1164
Phase 389
Early Phase 156
By status
Completed507
Terminated89
Unknown75
Recruiting58
Not yet recruit...35
Top countries
United States of America260
China60
France36
Japan29
South Korea27
Top sponsors
GlaxoSmithKline28
Pfizer24
Eli Lilly and Comp...23
Avid Radiopharmace...21
Merck Sharp & Dohm...17
Recent trials
Latest clinical trials for Alzheimer's Disease
A Study to Evaluate the Safety and Biomarker Effects of RO7269162 in Participants at Risk for or at the Prodromal Stage of Alzheimer's Disease (AD)
Hoffmann-La Roche · France,South Korea
NCT06402838Recruiting
Phase
Phase 2
A Post Marketing Study in Participants With Early Alzheimer's Disease Treated With Lecanemab
Eisai Co., Ltd. · Japan
NCT06322667Recruiting
Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia Taking Stable Donepezil Treatment (MK-1167-007)
Merck Sharp & Dohme LLC
NCT06285240Not yet recr...
Phase
Phase 1
Attenuation of Postprandial Inflammatory Processes in Alzheimer's Disease Patients by Consumption of Pomace Oil
Spanish National Research Coun... · Spain
NCT06245616Recruiting
[18F]Florbetazine ([18F]92) for Beta Amyloid PET Imaging in Alzheimer's Disease
Peking Union Medical College H... · China
NCT06141356Recruiting
Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease
GlaxoSmithKline · Argentina,Australia,Canada,Finland,France,Germany,Italy,Netherlands,Norway,South Korea,Spain,Sweden,
NCT06079190Not yet recr...
Phase
Phase 2
A Community-Based Screening Program to Identify Participants at High Risk for Amyloid Pathology
Eisai Limited · United States of America
NCT06043700Recruiting
Development of Multimodal Fusion Warning System and Non-invasive Techniques for Early Alzheimer's Detection.
First Affiliated Hospital of Z... · China
NCT05978830Recruiting
Theta Burst Stimulation for Mild to Moderate Alzheimer's disease.
Bionics Institute of Australia · Australia
ANZCTR12623000668606Not yet recr...
Phase
Not Applicable
An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's Disease
Green Valley (Shanghai) Pharma... · China
NCT05908695Not yet recr...
Phase
Phase 4
Study of 50561 in Patients With Mild or Moderate Alzheimer's Disease
Beijing Joekai Biotechnology L... · China
NCT05811442Recruiting
Phase
Phase 2
A Multiple Ascending Dose Study in Healthy Volunteers and Patients With Alzheimer's Disease
Allyx Therapeutics · United States of America
NCT05804383Recruiting
Phase
Phase 1
Safety, Tolerability and Pharmacokinetics of AD16 Tablets in Adult Healthy Subjects After Single Administration
Xiangya Hospital of Central So... · China
NCT05787028Completed
Phase
Phase 1
Untitled Trial
MSD K.K.
jRCT2031220627Recruiting
Safety and Pharmacokinetics of Single Ascending Doses and Multiple Ascending Doses of CS6253 in Healthy Volunteers
Artery Therapeutics, Inc.
NCT05965414Not yet recr...
Phase
Phase 1
Effectiveness of a Combined Reminiscence Therapy, Coffee Therapy, and Activities of Daily Living Practice Intervention for Older People with Moderate-to-Severe Alzheimer's Disease: A Retrospective Time Series Study
Seijoh University · Japan
UMIN000050094Completed
A Long-term Extension Study to Evaluate Safety, Tolerability, and Efficacy of AL002 in Alzheimer's Disease
Alector Inc. · United States of America
NCT05744401Recruiting
Phase
Phase 2
Safety, Tolerability and Pharmacodynamics of SHR-1707 in Alzheimer's Disease Patients.
Shanghai Hengrui Pharmaceutica...
NCT05681819Not yet recr...
Phase
Phase 1
Tau PET/CT Imaging in the Mismatch Prospective Cohort Study (MPC-TAU)
University of Pennsylvania · United States of America
NCT05658913Recruiting
Untitled Trial
Eli Lilly Japan K.K. · United States of America
jRCT2031220471Recruiting
View all 801 trials →
About this profile

Access comprehensive clinical trial information for Alzheimer's Disease through Pure Global AI's free database. This collection includes 801 clinical trials across multiple phases including N/A, Phase 2, Phase 1. Currently, 58 trials are actively recruiting participants.

Research for Alzheimer's Disease is being conducted in United States of America, China, France and 7+ other countries. Leading sponsors include GlaxoSmithKline and Pfizer. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 801 clinical trials studying Alzheimer's Disease, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include GlaxoSmithKline, Pfizer, Eli Lilly and Company, among others.